The correlation between fibroblast growth factor-23 and ESRD patients with hearing impairment.

Nie, Jingwen; Li, Qing; Guo, Min; Li, Jiaqing; Yang, Jiahui; Chang, Qing; Cai, Yaping

Nie, Jingwen; Li, Qing; Guo, Min; Li, Jiaqing; Yang, Jiahui; Chang, Qing; Cai, Yaping.

Afiliação

Nie J; Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Li Q; Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Guo M; Department of Otolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Li J; Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yang J; Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Chang Q; Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Cai Y; Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.

PeerJ ; 9: e12295, 2021.

Article em En | MEDLINE | ID: mdl-34721981

Palavras-chave

Chronic kidney disease; End-stage renal disease; Fibroblast growth factor-23; Hearing impairment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: PeerJ Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google